Induction of hypoxia-inducible factor 1α gene expression by vascular endothelial growth factor

被引:38
作者
Deudero, Juan Jose P. [1 ]
Caramelo, Carlos [1 ]
Castellanos, Maria Carmen [2 ]
Neria, Fernando [1 ]
Fernandez-Sanchez, Ruth [1 ]
Calabia, Olalla [1 ]
Penate, Silvia [1 ]
Gonzalez-Pacheco, Francisco Roman [1 ]
机构
[1] Univ Autonoma Madrid, Lab Nefrol Hipertens, Fdn Jimenez Diaz Capio, Madrid 28040, Spain
[2] Univ Autonoma Madrid, Serv Inmunol, Hosp Princesa, Madrid 28040, Spain
关键词
D O I
10.1074/jbc.M703875200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional regulation of vascular endothelial growth factor (VEGF) is critically dependent on hypoxia-inducible factor 1 (HIF-1). However, not only hypoxia, but selected growth factors can induce HIF-1. High levels of both VEGF and HIF-1 coexist in certain conditions, e. g. tumors. Nonetheless, the possibility that the stimulatory relationship between HIF-1 and VEGF may be bi-directional has not been addressed up to date. The present study in endothelial cells analyzed whether HIF-1 is regulated by a product of its own transcriptionally activated genes, namely, VEGF. As a main finding, VEGF-A165 induced the increase of HIF-1 alpha mRNA and HIF-1 alpha protein and nuclear translocation. Autologous endothelial cell VEGF mRNA and protein were also increased upon exposure to exogenous VEGF. The signaling implication of reactive oxygen species was examined by comparison with H2O2 and hypoxanthine/xanthine oxidase and by the superoxide dismutase mimetic, MnTMPyP, the Rac1-NAD(P) H oxidase complex inhibitor, apocynin, transfection of a dominant negative Rac1 mutant, and transfection of a p67phox antisense oligonucleotide. Superoxide anion, largely dependent on Rac1-NAD(P) H oxidase complex activity, was the critical signaling element. The transductional functionality of the pathway was confirmed by means of a reporter gene flanked by a transcription site-related VEGF sequence and by quantitative PCR. In summary, the present results reveal a previously undescribed action of VEGF on the expression of its own transcription factor, HIF-1, and on VEGF itself. This effect is principally mediated by superoxide anion, therefore identifying a new, potentially relevant role of reactive oxygen species in VEGF signaling.
引用
收藏
页码:11435 / 11444
页数:10
相关论文
共 49 条
[1]   Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock [J].
Abdelrahman, M ;
Mazzon, E ;
Bauer, M ;
Bauer, I ;
Delbosc, S ;
Cristol, JP ;
Patel, NSA ;
Cuzzocrea, S ;
Thiemermann, C .
SHOCK, 2005, 23 (02) :107-114
[2]   Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IκB/NF-κB [J].
Abid, MR ;
Schoots, IG ;
Spokes, KC ;
Wu, SQ ;
Mawhinney, C ;
Aird, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (42) :44030-44038
[3]   Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy [J].
Al-Shabrawey, M ;
Bartoli, M ;
El-Remessy, AB ;
Platt, DH ;
Matragoon, S ;
Behzadian, MA ;
Caldwell, RW ;
Caldwall, RB .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (02) :599-607
[4]   Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity [J].
Arroyo, MVA ;
Suzuki, Y ;
Yagüe, S ;
Lorz, C ;
Jiménez, S ;
Soto, C ;
Barat, A ;
Belda, E ;
González-Pacheco, FR ;
Deudero, JJP ;
Castilla, MA ;
Egido, J ;
Ortiz, A ;
Caramelo, C .
TRANSPLANTATION, 2002, 74 (11) :1618-1624
[5]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[6]  
Castilla MA, 1999, CIRC RES, V85, P1132
[7]   Pleiotropic renal actions of erythropoietin [J].
Chatterjee, PK .
LANCET, 2005, 365 (9474) :1890-1892
[8]   Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR [J].
Colavitti, R ;
Pani, G ;
Bedogni, B ;
Anzevino, R ;
Borrello, S ;
Waltenberger, J ;
Galeotti, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) :3101-3108
[9]  
Feldser D, 1999, CANCER RES, V59, P3915
[10]   Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611